Physician profile
Jessica Kim
NPI 1245941046
$1,139.74
in general payments reported to CMS, 2019-2025
15 companies · $742 in 2025
The $742 reported for 2025 was more than what 80% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $18.50 · 2024: $379 · 2025: $742.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,139.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $165.84 | 2024-2025 | |
| Phathom Pharmaceuticals, INC. | $160.93 | 2024-2025 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $153.54 | 2025 | Xifaxan |
| Intra-Sana Laboratories | $150.00 | 2024 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Ardelyx, INC. | $136.29 | 2024-2025 | Ibsrela |
| Regeneron Healthcare Solutions, INC. | $59.28 | 2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $57.83 | 2023-2025 | Entyvio, Gattex |
| Novo Nordisk INC | $55.32 | 2024-2025 | Wegovy |
| Pfizer INC. | $39.54 | 2025 | |
| Ethicon US, LLC | $37.76 | 2024 | Linx Reflux Management System |
| Madrigal Pharmaceuticals | $33.03 | 2025 | Rezdiffra |
| Exact Sciences Corporation | $30.59 | 2024-2025 | Cologuard Collection Kit |
| Janssen Biotech, INC. | $23.39 | 2025 | Tremfya |
| Evoke Pharma, INC. | $19.44 | 2025 | |
| Braintree Laboratories, INC. | $16.96 | 2024 | Suflave, Sutab |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.